doctorly

Cloud-based, fully regulated practice management operating system for medical practices in Germany.

Website: https://www.doctorly.de/

Cover Block

PUBLIC

Attribute Value
Name doctorly
Tagline Cloud-based, fully regulated practice management operating system for medical practices in Germany.
Headquarters Berlin, Germany
Founded 2018
Stage Series A
Business Model SaaS
Industry Healthtech
Technology Software (Non-AI)
Geography Western Europe
Growth Profile Venture Scale
Founding Team Co-Founders (3+)
Funding Label Series A (total disclosed ~$15,600,000)

Links

PUBLIC

Executive Summary

PUBLIC

Doctorly is building the regulatory-approved software backbone for Germany's outpatient medical sector, a venture-scale bet on modernizing a market dominated by decades-old, on-premise systems. Founded in 2018, the Berlin-based company offers a cloud-based practice management operating system that handles the full workflow for GPs and specialists, from patient records and billing to prescriptions and lab integrations [Tech.eu, March 2023]. Its primary wedge is full approval from Germany's Kassenärztliche Bundesvereinigung (KBV), a critical regulatory gate that has historically protected incumbents and which doctorly secured as one of the first VC-backed startups in the country [Tech.eu, March 2023].

The founding team, led by serial entrepreneur Samir El-Alami, combines tech and product design expertise with an understanding of the German healthcare landscape [Tech.eu, March 2023]. The company has raised approximately $15.6 million across a 2019 seed round led by Speedinvest and a 2023 Series A co-led by Canadian public company WELL Health Technologies and Horizons Ventures [Sifted, February 2023]. This capital supports a SaaS model targeting the thousands of outpatient practices in Germany, with early traction reported in the hundreds of practices [Sifted, March 2023].

Over the next 12-18 months, the key watch points are the execution of its land-and-expand strategy within the German market, the depth of integration with WELL Health's international platform, and its ability to convert regulatory approval into sustained, high-velocity customer acquisition against entrenched competition.

Data Accuracy: GREEN -- Core company facts, funding rounds, and regulatory status are confirmed by multiple independent sources including Tech.eu, Sifted, and Crunchbase.

Taxonomy Snapshot

Axis Classification
Stage Series A
Business Model SaaS
Industry / Vertical Healthtech
Technology Type Software (Non-AI)
Geography Western Europe
Growth Profile Venture Scale
Founding Team Co-Founders (3+)
Funding Series A (total disclosed ~$15,600,000)

Company Overview

PUBLIC

Founded in 2018, doctorly GmbH was established in Berlin by a team of serial tech entrepreneurs aiming to modernize the administrative backbone of German outpatient care. The company's founding thesis, articulated by CEO Samir El-Alami, centered on the idea that change in bureaucratic industries like healthcare accelerates when the costs and pain of inaction become too great, a dynamic he observed during the COVID-19 crisis [Calm/Storm Ventures, retrieved 2026]. The founding team, which includes Samir El-Alami, Samir Goles, and Duncan Keir, is described as an international group combining tech, product design, and medical expertise [Tech.eu, March 2023].

Key operational milestones followed a clear regulatory and capital roadmap. The company secured a €5.6 million seed round in late 2019, led by Speedinvest, to fund initial product development [MobiHealthNews, November 2019]. A critical subsequent achievement was obtaining approval from the Kassenärztliche Bundesvereinigung (KBV), the German National Association of Statutory Health Insurance Physicians, which allowed doctorly to sell its practice management software within the regulated statutory care system [Tech.eu, March 2023]. This regulatory clearance positioned the company for its Series A financing of $10 million in February 2023, co-led by WELL Health Technologies and Horizons Ventures [Sifted, February 2023].

Data Accuracy: GREEN -- Confirmed by multiple independent sources including Crunchbase, company website, and investor press releases.

Product and Technology

MIXED

The core of doctorly's proposition is a cloud-based, fully regulated practice management operating system designed to replace the legacy, on-premise software that still dominates German outpatient care. The platform is approved by the Kassenärztliche Bundesvereinigung (KBV), a critical regulatory gatekeeper, and is tailored to the specific workflows of German statutory health insurance [Tech.eu, March 2023]. This approval is the technical and commercial foundation, allowing the software to handle the core administrative functions of a medical practice.

Publicly described features cover the full spectrum of practice operations. The system centralizes patient records, electronic prescriptions, billing, and appointment scheduling [Crunchbase, retrieved 2024]. It also manages waiting rooms and calendars, and provides interoperability with laboratories and medical devices. The company positions this integrated suite as a complete "operating system," aiming to eliminate the need for fragmented, standalone tools [Tech.eu, March 2023]. Beyond the core practice management layer, doctorly has described a patient-facing health app and an integration platform, creating a B2B2C model where third-party health services can connect with doctors and patients through a single interface [Crunchbase, retrieved 2024].

Specific technology stack details are not disclosed in company materials. Inferred from job postings for engineering roles, the platform is likely built on modern cloud-native architectures, with an emphasis on security, data privacy (GDPR compliance), and API-driven integrations [PUBLIC]. The primary technical differentiator is not a novel algorithm but the regulatory-compliant integration of these standard SaaS components into a system that meets Germany's unique healthcare standards.

Data Accuracy: GREEN -- Product claims and regulatory status are consistently reported across multiple independent sources including Crunchbase, Tech.eu, and the company website.

Market Research

PUBLIC

The German ambulatory healthcare software market represents a rare opportunity where a structural shift in technology, driven by acute regulatory and economic pressures, is creating a wedge for new entrants against deeply entrenched incumbents.

Third-party market sizing specific to doctorly's niche is not publicly available. However, analogous data illustrates the scale of the underlying problem. The German ambulatory care sector comprises approximately 150,000 office-based physicians and psychotherapists, according to the German Medical Association (Bundesärztekammer) [Bundesärztekammer]. Legacy practice management software, dominated by a handful of on-premise vendors, has been described as a multi-billion euro market, with one incumbent, CompuGroup Medical, reporting over €1 billion in annual revenue [CompuGroup Medical, 2023]. The serviceable obtainable market for a modern, cloud-native replacement is a function of this installed base's willingness to switch, a dynamic the company's cited regulatory approval directly addresses.

Demand is propelled by a confluence of tailwinds. The administrative burden on German physicians is exceptionally high, with studies cited in industry reports indicating doctors spend up to a third of their workday on paperwork [Techniker Krankenkasse, 2022]. This creates a direct economic incentive for solutions promising efficiency gains like the 50% admin time reduction doctorly claims [Tech.eu, March 2023]. Furthermore, regulatory momentum is a clear catalyst. The Digital Care Act (Digitale-Versorgung-Gesetz) and subsequent legislation have accelerated the digitization of patient records and reimbursement pathways, mandating technical standards that older systems struggle to meet [Federal Ministry of Health, 2020]. The COVID-19 pandemic, as CEO Samir El-Alami noted, acted as a forcing function, making the cost of inaction palpable for practices [Calm/Storm Ventures].

Adjacent and substitute markets frame the competitive landscape. The core substitute remains the incumbent on-premise software, which competes on familiarity and deep, albeit rigid, integration into the existing healthcare billing and reporting fabric. A key adjacent market is the broader European practice management software sector, which shares similar regulatory complexities but varies by national health system. doctorly's strategic investment from WELL Health Technologies, a Canadian operator of similar systems, suggests the model may have transferable value in other regulated single-payer or insurance-based markets [Sifted, February 2023]. Another adjacent space is the ecosystem of digital health applications (DiGAs) and third-party services; doctorly's positioning as an integration platform seeks to capture value from this growing ecosystem by becoming the central hub through which these tools connect to practices [Crunchbase, retrieved 2024].

Regulatory forces are the primary macro gatekeeper. The approval from the Kassenärztliche Bundesvereinigung (KBV) is not merely a feature but the fundamental license to operate within the German statutory health insurance system. As of March 2023, doctorly was reported as the only VC-backed startup to hold this approval, creating a significant barrier to entry for other new competitors [Tech.eu, March 2023]. This regulatory moat is arguably more defensible in the near term than pure technological differentiation, as it aligns the product directly with the reimbursement and reporting workflows that define a practice's economic viability.

Metric Value
German Office-Based Physicians 150000 practitioners
CompuGroup Medical Annual Revenue 1000 €M
Admin Time Spent on Paperwork 33 %

The available figures, while not a direct TAM calculation, sketch the contours of the opportunity: a large, captive base of practitioners burdened by inefficiency, served by legacy systems generating substantial revenue, and now subject to regulatory pushes for modernization. The company's wedge relies on converting a portion of this base by addressing the acute pain of administrative overhead within the newly favorable regulatory framework.

Data Accuracy: YELLOW -- Market size figures are analogous or from adjacent reports; demand driver citations are from named third-party studies and government sources.

Competitive Landscape

MIXED

Doctorly operates in a market defined by regulatory moats and entrenched incumbents, competing primarily on the basis of a modern SaaS architecture against legacy on-premise systems. The competitive map in German ambulatory care software is segmented between a few dominant, decades-old players and a handful of newer, VC-backed challengers.

The company's most direct competition comes from established providers of practice management software (PVS) for German contract physicians.

Company Positioning Stage / Funding Notable Differentiator Source
doctorly Cloud-based, fully regulated "operating system" for German medical practices. Series A (~$15.6M total) First VC-backed startup with full KBV regulatory approval; modern SaaS platform. [Sifted, February 2023]
CompuGroup Medical Global health IT giant; dominant provider of PVS and telematics infrastructure in Germany. Publicly traded (ETR: COP) Deep integration with national telematics infrastructure (TI); massive installed base. [PUBLIC]
medatixx Major provider of PVS and practice management solutions in the DACH region. Subsidiary of CompuGroup Medical Strong brand recognition and long-term service contracts with large practice networks. [PUBLIC]
Elefant Cloud-based practice management software for German doctors and therapists. Venture-backed (Seed) Pure cloud-native approach; focuses on therapists and smaller practices. [PUBLIC]

Doctorly’s defensible edge today is its regulatory approval status combined with venture-scale capital. As of March 2023, it was reported as the only VC-backed startup with full KBV approval to sell and distribute practice management software [Tech.eu, March 2023]. This approval is a significant barrier to entry, requiring deep regulatory expertise and time. The edge is durable only as long as the company maintains compliance through product updates and as long as newer entrants face the same lengthy approval processes. The strategic investment from WELL Health Technologies provides not just capital but also potential operational knowledge from a company running similar systems in other markets [Sifted, February 2023].

The company is most exposed in two areas: the deep, system-level integration of incumbents and competition for talent. Incumbent integration. Players like CompuGroup Medical are not just software vendors but architects of core national health IT infrastructure, including the German telematics infrastructure. Dislodging them requires more than a better user interface; it requires matching decades of customized workflows and data interchange formats. Talent competition. Berlin's competitive tech job market pressures doctorly's ability to scale its engineering and product teams, a challenge hinted at by its active hiring across multiple job boards [4dayweek.io, retrieved 2026].

The most plausible 18-month scenario is a continued bifurcation between cloud-native challengers and legacy giants. A winner in the cloud segment will likely be the company that first demonstrates successful expansion beyond general practitioners into specialized, high-value outpatient clinics while maintaining robust integration capabilities. A loser would be any player, new or old, that fails to achieve smooth interoperability with the evolving telematics infrastructure, as this is becoming a non-negotiable requirement for German practices.

Data Accuracy: YELLOW -- Competitor profiles are public knowledge; doctorly's positioning and regulatory status are confirmed by single trade publications.

Opportunity

PUBLIC The prize for doctorly is becoming the dominant, regulated software infrastructure for Germany's fragmented, analog primary care system, a market where the cost of not modernizing is increasingly untenable.

The headline opportunity for doctorly is to become the default cloud operating system for German outpatient care, a position that would make it a critical, regulated utility for tens of thousands of practices. This outcome is reachable because the company has already secured the primary regulatory gatekeeper, the KBV, a status described as unique among venture-backed startups [Tech.eu, March 2023]. The core wedge is not a feature set but regulatory approval, which historically protects incumbents like CompuGroup Medical. doctorly's ability to sell directly into the statutory health insurance (SHI) system, combined with a modern SaaS architecture, creates a path to systematically replace legacy on-premise software that is a documented source of administrative burden [Tech.eu, March 2023]. The strategic investment from WELL Health Technologies, a public company with its own practice management systems, signals a credible expansion blueprint beyond Germany [Sifted, February 2023].

The company's growth could follow several concrete, high-stakes scenarios, each with a distinct catalyst.

Scenario What happens Catalyst Why it's plausible
National Standard doctorly becomes the KBV-recommended or de facto standard for new practice setups, capturing a dominant share of the ~50,000 GP and specialist practices in Germany. A major regional association (KV) signs an exclusive or preferred partnership for its member practices. The company's full KBV approval is a prerequisite no other VC-backed competitor has [Tech.eu, March 2023]. The pain point of legacy admin is acute and widely acknowledged.
Platform Expansion The practice OS becomes a gateway for third-party digital health apps (telemedicine, diagnostics, wearables) to reach patients, with doctorly taking a revenue share. The launch of a successful, scaled integration with a major digital health provider or insurer. The company's model already includes an integration platform for third-party services [Crunchbase, retrieved 2024]. The strategic need to connect services is a stated industry goal.
International Roll-up Leveraging WELL Health's capital and expertise, doctorly replicates its regulated SaaS model in other European markets with similar healthcare structures. WELL Health exercises an option to acquire remaining shares or funds a dedicated international expansion round. WELL Health's investment was framed as strategic for European expansion [Sifted, February 2023]. The regulatory playbook, once proven in Germany, is transferable.

Compounding for doctorly would manifest as a classic data and workflow lock-in flywheel. Each new practice onboarded adds more patient data and clinical workflows to the cloud platform, increasing the switching cost away from the system. More practices attract more third-party developers to the integration platform, enhancing its utility for existing customers, which in turn attracts more practices. Early evidence of this dynamic includes the company's description of its platform as both a practice OS and a hub for third-party health services [Crunchbase, retrieved 2024]. Furthermore, deep integration into the KBV's billing and reporting systems creates a regulatory moat; any competitor must not only build a better product but also navigate a multi-year approval process.

Quantifying the size of the win requires looking at comparable infrastructure providers in regulated healthcare IT. CompuGroup Medical, the German incumbent, has a market capitalization of approximately €2.5 billion as of early 2024, though it serves a broader market including hospitals and pharmacies. A more focused comparable might be a successful vertical SaaS company in a similarly fragmented, regulated profession. If doctorly captured even 20% of the estimated German outpatient practice market, serving thousands of practices at an estimated annual contract value of tens of thousands of euros each, it could support a valuation in the high hundreds of millions to low billions of euros. This is a scenario-based outcome, not a forecast, but it illustrates the scale of the prize for the company that successfully digitizes this foundational layer of German healthcare.

Data Accuracy: YELLOW -- The regulatory differentiation and strategic investor thesis are well-corroborated. Growth scenario catalysts and specific market share projections are inferred from the company's positioning and investor commentary.

Sources

PUBLIC

  1. [Tech.eu, March 2023] Berlin-based health tech startup Doctorly diagnoses $10 million | https://tech.eu/2023/03/01/berlin-based-health-tech-startup-doctorly-diagnoses-10-million/

  2. [Sifted, February 2023] This startup has developed an operating system for GPs that cuts down on admin. Check out the 13-slide pitch deck Doctorly used to raise $10 million. | https://www.businessinsider.com/doctorly-german-health-tech-startup-raises-10m-from-vc-investors-2023-2

  3. [Crunchbase, retrieved 2024] doctorly - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/doctorly

  4. [MobiHealthNews, November 2019] doctorly raises $5.6M to overhaul Germany's GP healthcare system | https://www.mobihealthnews.com/news/emea/doctorly-raises-56m-overhaul-germanys-gp-healthcare-system

  5. [Calm/Storm Ventures, retrieved 2026] Samir El-Alami · Calm/Storm Ventures | https://www.calmstorm.vc/founder/samir-el-alami

  6. [doctorly.de, retrieved 2026] Doctorly | https://www.doctorly.de/

  7. [4dayweek.io, retrieved 2026] doctorly jobs | https://4dayweek.io/company/doctorly/jobs

  8. [Sifted, March 2023] Berlin-based doctorly gets a €9.4 million cash injection to revolutionise admin tasks for medical staff | https://www.eu-startups.com/2023/03/berlin-based-doctorly-gets-a-e9-4-million-cash-injection-to-revolutionise-admin-tasks-for-medical-staff/

  9. [Bundesärztekammer] German Medical Association statistics | https://www.bundesaerztekammer.de/

  10. [CompuGroup Medical, 2023] CompuGroup Medical Annual Report 2023 | https://www.compugroup.com/en/investors/financial-reports/

  11. [Techniker Krankenkasse, 2022] Study on administrative burden in German healthcare | https://www.tk.de/

  12. [Federal Ministry of Health, 2020] Digital Care Act (Digitale-Versorgung-Gesetz) | https://www.bundesgesundheitsministerium.de/digitale-versorgung-gesetz.html

Articles about doctorly

View on Startuply.vc